US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
RG

RGC

Stock Regencell Bioscience Holdings Ltd
$5.64

Nasdaq Capital Market · Healthcare · HK

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-05-11 4 mo old

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
🟡 BULLISH LEAN
The main driver: outperforming the market by 11.4%, RSI in healthy zone. More signals pointing up than down. Not...
56
of 100
Setup confidence — system conviction, not win probabilityC
Trade plan HOD_BREAK · SCALP
Entry
$6.24
Stop
$6.10
Target
$6.52
Risk : Reward 2.0R
Why this signal?
Structure2 of 5 timeframes bullish · 69.6% aligned
VWAPPrice below VWAP ($6.61)
VolumeRelative volume 7.7× the 20-day average
Momentum10-day rate of change +4.2%
Overall readBULLISH LEAN

Regencell Bioscience Holdings Ltd (RGC) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-05-11). See the full ratio breakdown and business-activity screen below for the reasoning. ⚠️ This provider verdict is about 4 months old (2026-05-11) — older than one reporting quarter, so it may predate the financial data shown below.

Market & analysts
Institutional own.
0.3%
of shares
Momentum (10d)
+4.2%
rate of change
SMC grade
C · 56
69.6% aligned
COMPLIANT
Sharia compliance
C · 56
SMC grade — 69.6% timeframe alignment
+4.2%
Rate of change (10d)
0.3%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for RGC — this runs off the critical path so the page paints first. It will appear here on its own.

52.8840.8628.8316.814.782025-09-122026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
4.76
S2
5.16
S1
5.40
PIVOT
5.80
R1
6.04
R2
6.44
R3
6.67

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
4.58 6.42
±16.72% from 5.50, made 2026-09-02 · resolves 2026-09-09
SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22591 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG BUY
5 buy · 2 neutral · 0 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)44.30NEUTRAL
Stochastic %K (14)19.28BUY
CCI (20)-11.91NEUTRAL
Williams %R (14)-80.72BUY
MACD (12,26,9)0.10BUY
ROC (10)2.17BUY
Momentum (10)0.12BUY
EMA (10)5.94SELL
SMA (10)6.01SELL
EMA (20)5.88SELL
SMA (20)5.74SELL
EMA (30)6.14SELL
SMA (30)5.68SELL
EMA (50)7.58SELL
SMA (50)5.69SELL
EMA (100)11.61SELL
SMA (100)13.93SELL
EMA (200)15.66SELL
SMA (200)19.78SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

regencellbioscience.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-02

HOD_BREAK
Type · SCALP
6.24
Entry
6.10
Stop
6.52
Target
LOSS
Outcome
Verdict

🟡 BULLISH LEAN

The main driver: outperforming the market by 11.4%, RSI in healthy zone. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert RGC [level]` to catch the entry, or `!plan RGC` to size small.

Scores: 3 bullish / 0 bearish

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

TimeframeBiasBars
📅 Daily BULLISH 62
⏰ 4H BULLISH 32
🕐 1H BEARISH 98
⏱ 15-Min RANGING 130
⏲ 5-Min RANGING 234

Momentum & Volume

-0.01
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.